| ZFIN ID: ZDB-PUB-121019-37 |
Investigations regarding the utility of prodigiosenes to treat leukemia
Smithen, D.A., Forrester, A.M., Corkery, D.P., Dellaire, G., Colpitts, J., McFarland, S.A., Berman, J.N., and Thompson, A.
| Date: | 2013 |
|---|---|
| Source: | Organic & biomolecular chemistry 11(1): 62-68 (Journal) |
| Registered Authors: | Berman, Jason, Corkery, Dale, Forrester, Michael |
| Keywords: | none |
| MeSH Terms: |
|
| PubMed: | 23070266 Full text @ Org. Biomol. Chem. |
Citation
Smithen, D.A., Forrester, A.M., Corkery, D.P., Dellaire, G., Colpitts, J., McFarland, S.A., Berman, J.N., and Thompson, A. (2013) Investigations regarding the utility of prodigiosenes to treat leukemia. Organic & biomolecular chemistry. 11(1):62-68.
ABSTRACT
Prodigiosenes, possessing a 4-methoxypyrrolyldipyrrin skeleton, are known for their anti-cancer activity. Structural modification of the C-ring resulted in a series of prodigiosenes that displayed promising activity against leukemia cell lines during in vitro analysis against the NCI 60 cancer cell line panel. Further in vivo studies of these compounds using the zebrafish model showed persistence of anti-leukemia properties in human K562 chronic myelogenous leukemia cells.
ADDITIONAL INFORMATION
- Genes / Markers (2)
- Mutations and Transgenics (2)
- Fish (1)